Ai-guided radiation planning for glioblastoma
Part of Cancer clinical trials.
This trial tests whether artificial intelligence can help plan radiation therapy better for people with a type of brain cancer called glioblastoma. It may lead to more precise treatment and fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been recently diagnosed with IDH wild-type glioblastoma (a specific type of brain tumor).
- You are able to have an MRI scan.
- Your performance status is 60 or higher on the Karnofsky scale (meaning you can care for most daily needs).
- Your life expectancy is at least 12 weeks.
- Your blood counts and liver/kidney function meet specific minimum levels.
- You have not had prior radiation to the brain or other cancer treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to plan radiation therapy for brain tumors (gliomas) using artificial intelligence. It aims to make treatment more precise and personalized for people with either aggressive (GBM) or slower-growing (IDH-mutant) gliomas.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This trial is testing a new way to find and remove glioblastoma brain tumors using a special MRI scan. It may help doctors remove more of the tumor safely during surgery.
This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.
This trial tests whether adding the study drug azeliragon to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma. The study will also look at how the tumor responds to the added drug.
This trial uses advanced imaging to help surgeons remove as much of a malignant brain tumor as safely possible. It may be a good fit if you have a new diagnosis of glioblastoma or a certain astrocytoma and are healthy enough for surgery.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.